Canmax Technologies Co., Ltd.: history, ownership, mission, how it works & makes money

From its founding in 1997 as a specialist in ultra-clean technology and medical equipment to its 2014 listing on the Shenzhen Stock Exchange (ticker 300390.SZ), Canmax Technologies has evolved into a diversified industrial player - rebranded in March 2023 and recording consecutive annual revenues above ¥10 billion between 2022-2023 while being named a top-500 private manufacturer in China in 2023; by December 8, 2025 the company commanded a market capitalization of ¥42.91 billion with roughly 830.75 million shares outstanding, insiders holding about 32.92% and institutions ~10.76%, and on December 1, 2025 CATL completed a share transfer making a strategic ¥2.6 billion investment as the second-largest shareholder; operating across lithium battery materials, anti‑static ultra‑clean tech and medical devices, Canmax runs major production bases including a 75,000 tpa lithium hydroxide plant in Yibin and a 60,000 tpa plant in Meishan, pursues R&D on sulfide solid electrolytes and low‑cost ultra‑pure lithium sulfide, and despite a 2024 revenue of ¥6.61 billion (a decline of 36.87% year‑on‑year) is leveraging partnerships, vertical integration and technology commercialization to capture opportunities in new energy, semiconductors and biomedicine - read on to explore its ownership dynamics, business model and growth prospects

Canmax Technologies Co., Ltd. (300390.SZ): Intro

• Founded: 1997 - initial focus on ultra-clean technology and medical equipment.
• Listed: 2014 - Shenzhen Stock Exchange, ticker 300390.SZ.
• Name change: March 2023 - Suzhou TA&A Ultra Clean Technology Co., Ltd. renamed to Canmax Technologies Co., Ltd. to reflect business diversification.
• Revenue scale: Consecutive annual revenues exceeding RMB 10 billion in 2022 and 2023.
• Recognition: 2023 - ranked among the top 500 private manufacturing enterprises in China.
• Major investor update: December 1, 2025 - completion of a share transfer agreement with CATL; CATL invested RMB 2.6 billion and became the second-largest shareholder.

• Product sales - core revenues from ultra-clean systems (cleanrooms, air filtration), precision filtration products, and medical disposables sold to semiconductor, pharmaceutical, biotech and healthcare customers.
• Project and engineering services - design, installation and maintenance of cleanroom facilities and integrated systems for industrial and healthcare clients.
• After-sales & consumables - recurring revenue from replacement filters, consumables, spare parts and service contracts.
• R&D-driven premium products - monetization through higher-margin specialized equipment and proprietary technologies tailored to semiconductor and life-science customers.
• Strategic equity partnerships - capital and strategic cooperation (e.g., CATL's RMB 2.6 billion investment) to support capacity expansion and downstream market access.

• Diversified product portfolio across high-demand sectors: semiconductors, biopharma, healthcare.
• Scale and revenue momentum: sustained >RMB 10 billion annual revenues across 2022-2023.
• Public-market access since 2014 enabling capital for growth and M&A.
• Strengthened strategic ties with leading battery/clean-energy player CATL following the RMB 2.6 billion share transfer.

Canmax Technologies Co., Ltd. (300390.SZ): History

• Shares outstanding (Dec 2025): 830.75 million
• Market capitalization (Dec 8, 2025): ¥42.91 billion
• Insider ownership: 32.92% (significant internal control)
• Institutional ownership: 10.76% (moderate external interest)
• Public float: remainder of shares, providing liquidity

• Evolution drivers: strategic M&A, private placements, board-level share allocations, and employee equity programs.
• Implications: concentrated insider stake supports long-term strategy alignment but limits free-float control; institutional stake room to grow as the company scales.
• Investor access: active public trading enables secondary-market liquidity for retail and non-insider investors.

Canmax Technologies Co., Ltd. (300390.SZ): Ownership Structure

• Mission: Become an international leader in innovative new energy technologies focused on sustainable development.
• Customer orientation: Prioritize client needs via high‑quality products and lifecycle services.
• Excellence & operational efficiency: Continuous improvement across manufacturing, supply chain and service delivery.
• Innovation: Significant R&D investment to drive product differentiation and technological leadership.
• Integrity: Transparent, ethical governance and compliance across markets.
• Pragmatism & win‑win approach: Seek practical engineering solutions and cooperative partner relationships.

How It Works & Core Business Lines

• Product development & R&D: inverters, energy storage systems, power conversion modules and integrated solutions for distributed energy and EV charging.
• Manufacturing & supply chain: vertically integrated production for key power electronics components.
• Project solutions & services: turn‑key system integration, after‑sales maintenance, and performance optimization.
• Sales channels: domestic utility and commercial contracts, exports to APAC/EMEA, and channel partners for B2B/B2C deployments.

How It Makes Money - Key Revenue Drivers

• Hardware sales: inverters, ESS racks and power modules-majority of revenue.
• System integration & project revenues: EPC and turn‑key installations for commercial & industrial clients.
• Recurring services: maintenance, software updates, extended warranties, and O&M contracts.
• Technology licensing and export margins from overseas projects.

Selected Financial & Operational Metrics (RMB, annual)

Ownership Breakdown (approximate)

• Board & governance: a board comprising executive and independent directors with oversight over R&D prioritization, internationalization and compliance.
• Capital allocation: persistent reinvestment into R&D and capacity expansion-R&D intensity rose to ~8.3% of revenue in 2023 to support advanced power electronics and energy storage roadmaps.
• Risk profile: exposure to commodity price swings (silicon, copper), trade policy for exports, and project contract cyclicality; mitigated by diversified product mix and recurring O&M revenues.

Canmax Technologies Co., Ltd. (300390.SZ): Mission and Values

• Primary business segments: new energy lithium battery materials, anti-static ultra-clean technology, medical devices.
• Large-scale production assets to support battery-materials leadership, including lithium hydroxide plants of 75,000 tpa (Yibin) and 60,000 tpa (Meishan).
• Collaborative R&D focus on sulfide solid electrolytes and low-cost ultra‑pure lithium sulfide to serve solid-state battery development.
• Supply-chain diversification across domestic and international suppliers for spodumene, lithium chemicals, and specialty reagents to ensure feedstock stability and cost control.
• Customer-centric product customization for semiconductor, advanced display and biomedicine sectors, with tailored cleanliness and anti-static specifications.
• Operational emphasis on quality control and environmental compliance to meet international product and emissions standards.

• Upstream sourcing: procurement of lithium raw materials (spodumene concentrates, lithium carbonate) and specialty chemicals from multiple regions to reduce single‑source exposure.
• Conversion & production: large-scale lithium hydroxide production (Yibin 75,000 tpa; Meishan 60,000 tpa) plus downstream processing into ultra-pure lithium derivatives for battery and solid-electrolyte applications.
• R&D & co-development: partnerships with top universities and research institutes to commercialize sulfide solid electrolytes and produce low-cost ultra-pure lithium sulfide suitable for solid-state cells.
• Quality & compliance: multi-stage QC labs and process controls to meet semiconductor- and medical-grade cleanliness and anti-static specifications; environmental management systems to limit emissions and effluents.
• Sales & customer solutions: product customization, technical support and co-design with OEMs in EV batteries, semiconductors and biomedical device manufacturing; blended pricing and long-term offtake for large customers.

• Product sales: bulk lithium hydroxide and specialty lithium derivatives sold to battery makers and chemical intermediaries (large-volume, contract and spot sales).
• Specialty materials & services: higher-margin anti-static ultra‑clean products and medical consumables sold to semiconductor, display and biomedical customers.
• Technology licensing & co-development: joint R&D projects and IP licensing around sulfide solid electrolytes and advanced purification processes.
• Long-term supply agreements: offtake contracts and strategic supply partnerships that stabilize cash flows and support plant utilization.

• Targeted R&D lines: sulfide solid electrolytes for all-solid-state batteries; low-cost ultra‑pure lithium sulfide suitable for industrial-scale adoption.
• Academic and industry partnerships: collaborative development with top universities and research institutes (material science and electrochemistry centers) to accelerate commercialization.
• Scale-up pathway: pilot-to-commercial lines integrated with Yibin and Meishan production capacity to move promising lab results into industrial output and reduce time-to-market.

• Quality systems: multi-stage testing for purity, particle-size distribution, moisture control and anti-static performance to meet semiconductor and biomedical grade standards.
• Environmental controls: wastewater treatment, VOC controls and closed-loop solvent handling in accordance with national environmental regulations and customer ESG requirements.
• Supply diversification: sourcing from multiple regions/partners for spodumene, lithium carbonate and specialty reagents to mitigate price volatility and continuity risks.

Canmax Technologies Co., Ltd. (300390.SZ): How It Works

• Primary manufacturing: battery-grade lithium hydroxide and lithium carbonate production for NEVs and grid energy storage; products sold to battery makers and electrolyte producers.
• Process & product tech: anti-static ultra-clean materials and process solutions sold to semiconductor and display fabs to improve yield and reliability.
• Medical device segment: sales of CT tubes, steep pulse therapy devices and ancillary components to hospitals and medical equipment distributors.
• Strategic investments & equity income: majority equity in targeted new-energy firms and joint ventures that provide financial returns and supply-chain integration.
• R&D commercialization: internally developed materials and process technologies licensed or produced at scale to open adjacent markets.

• Volume-based sales: recurring revenue from sale of lithium salts (by tonnage) and anti-static consumables (by unit/roll/batch).
• Contract manufacturing & OEM supply: long-term supply contracts with battery makers and semiconductor fabs lock in predictable revenue.
• Project and equipment sales: turnkey or component sales to medical institutions and cleanroom suppliers.
• Equity returns & dividends: income and investment income from subsidiaries and stakes (e.g., 75% stake in Suzhou Tianhua Times New Energy Industry Investment Co., Ltd.).
• Collaborative revenue: revenue-sharing, licensing fees, and co-developed product sales from partnerships with industry leaders (including collaboration with CATL).

• Investment: acquisition of a 75% stake in Suzhou Tianhua Times New Energy Industry Investment Co., Ltd. to secure upstream/downstream synergies and broaden new-energy footprint.
• Partnerships: technology and commercial collaborations with major battery makers (notably CATL) to co-develop lithium products, improve supply security and capture higher-margin finished-material sales.
• R&D focus: continuous investment in high-purity lithium chemistry, anti-static ultra-clean formulations and medical-grade components to lift ASPs and margin profile over time.

• R&D → pilot production: develop high-purity chemistries and anti-static formulations, validate in pilot lines.
• Scale-up manufacturing: move to commercial-scale plants for lithium salts and ultra-clean products; achieve industry specs for battery makers and fabs.
• Sales & contracts: secure long-term supply agreements with battery manufacturers and fabs; spot sales to capture price upside.
• Aftermarket & services: provide technical support, maintenance for medical devices and cleanroom consumables to retain customers and create recurring revenue.

Canmax Technologies Co., Ltd. (300390.SZ): How It Makes Money

• Primary revenue streams: sale of cathode/anode materials, electrolyte materials, battery precursor products, and customized material solutions to industrial customers.
• Adjunct revenue: R&D services, technology licensing, joint development contracts with large battery manufacturers, and selective M&A to integrate upstream or downstream capabilities.
• Channel & geographic mix: domestic OEMs remain core customers while increasing exports to international battery and automotive manufacturers to diversify demand.

• Founded as a battery-materials developer, later listed on Shenzhen Stock Exchange (300390.SZ) to scale manufacturing and R&D.
• Publicly traded structure with institutional and retail shareholders; strategic partnerships (notably CATL) provide off-take and co-development pathways.

• Mission: accelerate clean-energy electrification by supplying high-performance, lower-cost battery materials and enabling next-generation cell technologies.
• Position: a vertically focused materials supplier aiming for technology leadership in niche chemistries (solid-state, sulfur-based) while expanding into global markets.

• Partnerships with large OEMs (e.g., CATL) secure volume demand and co-development revenue streams.
• R&D into solid-state and lithium sulfide materials targets higher-margin, differentiated products that could command premium pricing if successfully commercialized.
• International expansion reduces exposure to domestic cyclical demand and opens new OEM contracts and licensing opportunities.
• Strategic acquisitions can fill capability gaps (scale, specialty chemistries) to increase total addressable market and cross-sell opportunities.